Identification of genes associated with non-small-cell lung cancer promotion and progression

Lantuejoul, 2006, Prognostic biomarkers in non-small-cell lung carcinoma, Curr Diag Pathol, 12, 418, 10.1016/j.cdip.2006.07.002 Lam, 2007, Lung cancer: future directions, Respirology, 12, 471, 10.1111/j.1440-1843.2007.01105.x Breuer, 2005, Molecular pathology of non-small-cell lung cancer, Respiration, 72, 313, 10.1159/000085376 Welsh, 1990, Fingerprinting genomes using PCR with arbitrary primers, Nucleic Acid Res, 18, 7213, 10.1093/nar/18.24.7213 Markovic, 2008, Genomic instability in patients with non-small cell lung cancer assessed by the arbitrarily primed polymerase chain reaction, Cancer Invest, 26, 262, 10.1080/07357900701708385 Achille, 1996, Scarpa A. Chromosome 7q allelic losses in pancreatic carcinoma, Cancer Res, 56, 3808 Luo, 2003, DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction, Cancer Res, 63, 6166 De Juan, 1999, DNA amplification on chromosome 6p12 in non small cell lung cancer detected by arbitrarily primed polymerase chain reaction, Int J Cancer, 84, 344, 10.1002/(SICI)1097-0215(19990820)84:4<344::AID-IJC2>3.0.CO;2-D Ong, 1998, Detection of genomic instability in lung cancer tissues by random amplified polymorphic DNA analysis, Carcinogenesis, 19, 233, 10.1093/carcin/19.1.233 Singh, 2001, Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting, Gene, 269, 33, 10.1016/S0378-1119(01)00458-9 Zhang, 2004, Genomic instability in hepatocellular carcinoma revealed by using the random amplified polymorphic DNA method, J Cancer Res Clin Oncol, 130, 757, 10.1007/s00432-004-0613-4 Chariyalertsak, 2005, Novel DNA amplification on chromosome 2p25.3 and 7q11. 23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction, J Cancer Res Clin Oncol, 131, 821, 10.1007/s00432-005-0031-2 2004 Sambrook, 1989 Cobb, 1997, Optimization of RAPD fingerprinting, 93 McClelland, 1994, DNA fingerprinting by arbitrarily primed PCR, PCR Methods, 4, S59, 10.1101/gr.4.1.S59 Antonarakis, 2002, The nature and mechanisms of human gene mutation, 7 Berditchevski, 2007, Tetraspanins as regulators of protein trafficking, Traffic, 8, 89, 10.1111/j.1600-0854.2006.00515.x Lazo, 2007, Functional implications of tetraspanin proteins in cancer biology, Cancer Sci, 98, 1666, 10.1111/j.1349-7006.2007.00584.x Higashiyama, 1995, Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer, Cancer Res, 55, 6040 Funakoshi, 2003, Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer, Oncogene, 22, 674, 10.1038/sj.onc.1206106 Uldry, 2001, Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain, EMBO J, 20, 4467, 10.1093/emboj/20.16.4467 Brognard, 2001, Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation, Cancer Res, 61, 3986 Wang, 2002, Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies, J Immunol, 169, 1102, 10.4049/jimmunol.169.2.1102 Pallasch, 2005, Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival, Int J Cancer, 117, 456, 10.1002/ijc.20929 Guengerich, 2000, Metabolism of chemical carcinogens, Carcinogenesis (Lond), 21, 345, 10.1093/carcin/21.3.345 Murray, 2000, The role of cytochrome P450 in tumour development and progression and its potential in therapy, J Pathol, 192, 419, 10.1002/1096-9896(2000)9999:9999<::AID-PATH750>3.0.CO;2-0 Quintieri, 2000, In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A, Cancer Res, 60, 3232 Lanier, 2001, On guard—activating NK cell receptors, Nat Immunol, 2, 23, 10.1038/83130 Carrega, 2008, Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells, Cancer, 112, 863, 10.1002/cncr.23239 Wu, 2002, Cloning and characterization of a novel all-trans retinol short-chain dehydrogenase/reductase from the RPE, Invest Ophthalmol Vis Sci, 43, 3365 Picozzi, 2003, Genomic organization and transcription of the human retinol dehydrogenase 10 (RDH10) gene, FEBS Lett, 554, 59, 10.1016/S0014-5793(03)01089-5 Epping, 2005, The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling, Cell, 122, 835, 10.1016/j.cell.2005.07.003 Lokshin, 1999, Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines, Anticancer Res, 19, 5251 Chalmers, 1999, Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma, Genomics, 57, 160, 10.1006/geno.1998.5717 Ikeda, 1997, Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor, Immunity, 6, 199, 10.1016/S1074-7613(00)80426-4 Sardet, 1995, E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle, PNAS, 92, 2403, 10.1073/pnas.92.6.2403 Sagara, 2003, Scapinin, a putative protein phosphatase-1 regulatory subunit associated with the nuclear nonchromatin structure, J Biol Chem, 278, 45611, 10.1074/jbc.M305227200 Flores-Delgado, 2007, A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis, J Proteome Res, 6, 1165, 10.1021/pr060504h